Skip to content

Clinical trials

Phase 3 Lymphoma, Non-Hodgkin trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 3 Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20101
20121
20131
20141
20152
20163
20172
20191
20201
20215
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting12
Completed9
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Bayer3
Genmab3
Acerta Pharma BV2
Hoffmann-La Roche2
AbbVie1
Amgen1
Eli Lilly and Company1
Janssen Research & Development, LLC1
MEI Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin26
Lymphoma, B-Cell8
Hematologic Diseases6
Lymphoma6
Leukemia, Lymphocytic, Chronic, B-Cell5
Neoplasms5
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Mantle-Cell3
Leukemia, B-Cell1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.